Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose...

FDA Recall #D-0146-2021 — Class II — December 3, 2020

Recall #D-0146-2021 Date: December 3, 2020 Classification: Class II Status: Terminated

Product Description

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77

Reason for Recall

Failed Dissolution Specifications

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

22,848 cartons

Distribution

Nationwide

Code Information

M900412 December 2020 M904772 February 2021 M915745 October 2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated